The market is predicted to rise from USD 408.44 Mn in 2026 to USD 643.1 Mn by 2033.
The increasing focus on drug development and discovery, market share expansion and market shaping strategies, and research and development of new products drive industry growth.
Genentech, Novartis, Pfizer, Roche, and Merck & Co. are some key industry players.
Challenges like a strict regulatory landscape and high research and development costs restrain market expansion.
The increasing focus on drug development and drug discovery activities, as well as share expansion and market shaping strategies, are some opportunities in the market.